Category: Clinical Trial
Clinical Trial market research reports by GlobalData
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Small Cell Lung Cancer therapeutics. Synopsis In 2022, there wil ... Read More
-
Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 Summary Food allergy (FA) is defined as an adverse immunologic response to food. While any food can cause an adverse reaction ... Read More
-
T-Cell Lymphomas Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
T-Cell Lymphomas Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 Summary T-cell lymphomas (TCL) are white blood cell malignancies and a subtype of non-Hodgkin lymphomas (NHL), representin ... Read More
-
Gouty Arthritis (Gout) Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Gouty Arthritis (Gout) Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Gout therapeutics. Synopsis In 2022, there will be more than 30 ... Read More
-
Insomnia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Insomnia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in insomnia therapeutics. Synopsis In 2022, there will be more than 730 million p ... Read More
-
Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, ... Read More
-
Sarcopenia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Sarcopenia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Sarcopenia therapeutics. Synopsis There are 51 million cases of sarcopenia i ... Read More
-
Vulvovaginal Candidiasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Vulvovaginal Candidiasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Vulvovaginal Candidiasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Triple-Negative Breast Cancer (TNBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Triple-Negative Breast Cancer (TNBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Triple-Negative Breast Cancer (TNBC) Clinical Trial Analysis by Trial Phase, Trial St ... Read More
-
Marfan Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Marfan Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Marfan Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sp ... Read More
-
Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sp ... Read More
-
Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, ... Read More
-
Sarcoidosis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021 Update
Sarcoidosis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021 Update Summary In sarcoidosis Vasoactive intestinal polypeptide receptor 1 is a major focus of drug developers. There are 19 drugs in the pipeline with 95% molecules present in early-to- ... Read More
-
Philippines Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Philippines Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape Summary GlobalData, the industry analysis specialist, has released its latest report: “Philippines Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimburseme ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022 Summary When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions to curb these potential disasters. The COVID-19 Clinical and Com ... Read More
-
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027 Summary This reports provides a data-driven overview of the current and future competitive landscape in osteosarcoma therapeutics. In osteosarcoma Cells expressing ganglioside GD2 ... Read More
-
Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026
Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026 Summary In gastroparesis Dopamine (D2) receptor is a major focus of drug developers. There are 17 drugs in the pipeline with 90% molecules present in early stage. Mid-sized Pharma ... Read More
-
Cervical Cancer Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
Cervical Cancer Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 Summary Cervical cancer is the second most common cancer in women under the age of 45: Chronic infection with high-risk onc ... Read More
-
Appetite (Eating) Disorders - Global Clinical Trials Review, 2022
Appetite (Eating) Disorders - Global Clinical Trials Review, 2022 Summary GlobalData's clinical trial report, “Appetite (Eating) Disorders - Global Clinical Trials Review, 2022 provides an overview of Appetite (Eating) Disorders Clinical trials scenario. This report provides top line data relating t ... Read More
-
Carpal Tunnel Syndrome - Global Clinical Trials Review, 2022
Carpal Tunnel Syndrome - Global Clinical Trials Review, 2022 Summary GlobalData's clinical trial report, “Carpal Tunnel Syndrome - Global Clinical Trials Review, 2022 provides an overview of Carpal Tunnel Syndrome Clinical trials scenario. This report provides top line data relating to the clinical ... Read More
-
Interstitial Cystitis (Painful Bladder Syndrome Bladder Pain Syndrome) - Global Clinical Trials Review, 2022
Interstitial Cystitis (Painful Bladder Syndrome Bladder Pain Syndrome) - Global Clinical Trials Review, 2022 Summary GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome Bladder Pain Syndrome) - Global Clinical Trials Review, 2022 provides an overview of Interstitial ... Read More
-
Alcohol Addiction - Global Clinical Trials Review, 2022
Alcohol Addiction - Global Clinical Trials Review, 2022 Summary GlobalData's clinical trial report, “Alcohol Addiction - Global Clinical Trials Review, 2022 provides an overview of Alcohol Addiction Clinical trials scenario. This report provides top line data relating to the clinical trials on Alcoh ... Read More
-
Trigeminal Neuralgia (Tic Douloureux) - Global Clinical Trials Review, 2022
Trigeminal Neuralgia (Tic Douloureux) - Global Clinical Trials Review, 2022 Summary GlobalData's clinical trial report, “Trigeminal Neuralgia (Tic Douloureux) - Global Clinical Trials Review, 2022 provides an overview of Trigeminal Neuralgia (Tic Douloureux) Clinical trials scenario. This report pro ... Read More
-
Childhood Epilepsy Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
Childhood Epilepsy Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027 Summary In Childhood Epilepsy Gamma-aminobutyric acid type A receptor (GABA(A) receptor) is a major focus of drug developers. There are 27 drugs in the pipeline with 79% mole ... Read More
-
Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030
Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030 Summary Fragile X syndrome (FXS) (ICD-10: Q99.2) is an X-linked genetic condition and is the most common cause of inhe ... Read More
Research Assistance
